Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | KRAS | P01116 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13844344 | 0.76 | CHRM2 (0.44) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL14942714 | 0.74 | CHRM2 (0.39) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL12259635 | 0.74 | CHRM2 (0.39) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| Hydrochloric Acid SCHEMBL2391000 | 0.72 | CHRM2 (0.38) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL15998536 | 0.71 | CHRM2 (0.37) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL22629097 | 0.71 | HSD11B1 (0.44) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL13105097 | 0.71 | CHRM2 (0.41) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL13095272 | 0.71 | HSD11B1 (0.38) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL22628919 | 0.69 | HSD11B1 (0.47) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 | |
| SCHEMBL15116407 | 0.69 | CHRM2 (0.36) | CHRM2SLC6A2SLC6A4SLC6A3HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2020-12-17 | — | — | US | disclosed |
| WO-2018114596-A1 | SUBSTITUTED HETEROARYL PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | DDT, NOTUM, AGPS | CHRM2 1499/4885SLC6A2 1743/4885SLC6A4 1500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.